Evidence map›Paper›PMID 32270911›Full record

ArticleEMBO reports2020

IκBα deficiency imposes a fetal phenotype to intestinal stem cells.

Laura Marruecos, Joan Bertran, Yolanda Guillén, Jéssica González, Raquel Batlle, Erika López-Arribillaga, Marta Garrido, Cristina Ruiz-Herguido, Dominique Lisiero, Mónica González-Farré and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Post-translational Modifications of IκBα: The State of the Art.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Laura MarruecosCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Joan BertranCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Yolanda GuillénCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Jéssica GonzálezCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Raquel BatlleInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0003-3366-1393
Erika López-ArribillagaCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Marta GarridoCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Cristina Ruiz-HerguidoCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Dominique LisieroThe McArdle Laboratory of Cancer Research, University of Wisconsin, Madison, WI, USA.
Mónica González-FarréDepartment of Pathology, CIBERONC, University Autonomous of Barcelona, Hospital del Mar, Barcelona, Spain.
Sara Arce-GallegoCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.
Mar IglesiasDepartment of Pathology, CIBERONC, University Autonomous of Barcelona, Hospital del Mar, Barcelona, Spain.
Angel R NebredaInstitute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0002-7631-4060
Shigeki MiyamotoThe McArdle Laboratory of Cancer Research, University of Wisconsin, Madison, WI, USA.
Anna BigasCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.ORCID 0000-0003-4801-6899
Lluís EspinosaCancer Research Program, CIBERONC, Institut Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain.ORCID 0000-0002-2897-4099
Hospital del Mar Research Institute · ESCentro de Investigación Biomédica en Red de Cáncer · ESUniversity of Wisconsin–Madison · USInstitució Catalana de Recerca i Estudis Avançats · ESInstitute for Research in Biomedicine · ESUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Generalitat de Catalunya (Government of Catalonia) 2017SGR135Government of Catalonia |Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) 2015FI-B00806Government of Catalonia |Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) 2016FI-B1 00110Government of Catalonia | Departament de Salut, Generalitat de Catalunya SLT002/16/00070MEC | Instituto de Salud Carlos III (ISCIII) PI16/00437MEC | Instituto de Salud Carlos III (ISCIII) PIE15/00008
6 · The paper itself

Abstract

The intestinal epithelium is a paradigm of adult tissue in constant regeneration that is supported by intestinal stem cells (ISCs). The mechanisms regulating ISC homeostasis after injury are poorly understood. We previously demonstrated that IκBα, the main regulator of NF-κB, exerts alternative nuclear functions as cytokine sensor in a subset of PRC2-regulated genes. Here, we show that nuclear IκBα is present in the ISC compartment. Mice deficient for IκBα show altered intestinal cell differentiation with persistence of a fetal-like ISC phenotype, associated with aberrant PRC2 activity at specific loci. Moreover, IκBα-deficient intestinal cells produce morphologically aberrant organoids carrying a PRC2-dependent fetal-like transcriptional signature. DSS treatment, which induces acute damage in the colonic epithelium of mice, results in a temporary loss of nuclear P-IκBα and its subsequent accumulation in early CD44-positive regenerating areas. Importantly, IκBα-deficient mice show higher resistance to damage, likely due to the persistent fetal-like ISC phenotype. These results highlight intestinal IκBα as a chromatin sensor of inflammation in the ISC compartment.

Indexed as

IntestinesStem CellsAnimalsIntestinal MucosaMiceNF-KappaB Inhibitor alphaPhenotypeNF-KappaB Inhibitor alphafetal-like phenotypeintestinal stem cellsIκBαpolycombregeneration

Identifiers

PMID32270911
PMCPMC7271649
OpenAlexW3015625860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.